BioSpace News Archive

Grantz will focus on increasing Graminex brand recognition, by developing a more defined scientific understanding of Graminex® Flower Pollen Extract™ products.

The Public Health Agency of Canada is collaborating with provincial and territorial public health partners, the Canadian Food Inspection Agency and Health Canada to investigate an outbreak of Salmonella infections.

Trauma center accreditation status has been granted to one additional hospital in Pennsylvania starting November 1, 2019.

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced the appointment of Steve Davis to Heron’s Board of Directors.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced it will present data analyses evaluating the long-term effects of once-daily 40 mg INGREZZA® (valbenazine) in adults with tardive dyskinesia (TD), an involuntary movement disorder.

FORMA Therapeutics, Inc. today announced that new data related to FT-4101, its novel, small molecule fatty acid synthase (FASN) inhibitor, in clinical development for the treatment of nonalcoholic steatohepatitis (NASH), will be presented at The Liver Meeting® 2019, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) taking place November 8-12, 2019 in Boston, MA.

Dicerna™ Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved the grant of inducement stock options to purchase a total of 229,000 shares of common stock to be distributed among 10 new employees, with a grant date of October 1, 2019.

Author John Hawkins has written a well-researched biography about Termeer’s legacy—how he built a global biotech giant, Genzyme, and mentored a new generation of business leaders who continue to relentlessly challenge conventional innovation models and bring new novel treatments to patients around the world.

The U.S. Department’s Economic Development Administration (EDA) announced on Sept. 30, that it is investing $28.6 million in the University of the Virgin Islands to support efforts to diversify and strengthen the resiliency of the economy by helping to grow the medical sector, primarily by investing in the medical school project and the medical simulation center.

Johnson & Johnson (NYSE: JNJ) and its Janssen Pharmaceutical Companies today announced a settlement agreement with the Ohio counties of Cuyahoga and Summit that resolves all of the counties’ claims with no admission of liability and removes the Company from the federal trial scheduled to begin October 21, 2019.